XML 84 R67.htm IDEA: XBRL DOCUMENT v3.10.0.1
OTHER INCOME (NET) OTHER INCOME (NET) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]      
Interest Expense $ 183 $ 196 $ 167
Investment Income, Interest (173) (126) (97)
Loss/(gain) on equity investments 512 (23) 37
Restructuring Charges 131 293 109
Gain (Loss) Related to Litigation Settlement 76 (487) 47
Equity in net loss of affiliates (93) (75) (77)
Divestiture gain (178) (164) (576)
Other Income Received From Alliance Partners (1,353) (1,351) (719)
Alliance Transitional Services (12) (37) (238)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) (27) (1) (72)
Impairment of Intangible Assets, Finite-lived 64 0 15
Gain (Loss) on Extinguishment of Debt 0 109 0
Other Other Income Expense 20 (16) (44)
Other Nonoperating Income (Expense) (850) (1,682) $ (1,448)
Proceeds from Legal Settlements   481  
Nektar [Member]      
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]      
Loss/(gain) on equity investments $ 534    
Biogen & Roche [Member]      
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]      
Upfront licensing fees   $ 470